Colite tóxica e megacólon tóxico

Referências

Principais artigos

Ausch C, Madoff RD, Gnant M, et al. Aetiology and surgical management of toxic megacolon. Colorectal Dis. 2006 Mar;8(3):195-201. Resumo

Sheth SG, LaMont JT. Toxic megacolon. Lancet. 1998 Feb 14;351(9101):509-13. Resumo

Klobuka AJ, Markelov A. Current status of surgical treatment for fulminant clostridium difficile colitis. World J Gastrointest Surg. 2013 Jun 27;5(6):167-72.Texto completo  Resumo

Teeuwen PH, Stommel MW, Bremers AJ, et al. Colectomy in patients with acute colitis: a systematic review. J Gastrointest Surg. 2009 Apr;13(4):676-86. Resumo

Berman L, Carling T, Fitzgerald TN, et al. Defining surgical therapy for pseudomembranous colitis with toxic megacolon. J Clin Gastroenterol. 2008 May-Jun;42(5):476-80. Resumo

Artigos de referência

1. Marshak RH, Lester LJ. Megacolon a complication of ulcerative colitis. Gastroenterology. 1950 Dec;16(4):768-72. Resumo

2. Grieco MB, Bordan DL, Geiss AC, et al. Toxic megacolon complicating Crohn's colitis. Ann Surg. 1980 Jan;191(1):75-80.Texto completo  Resumo

3. Greenstein AJ, Sachar DB, Gibas A, et al. Outcome of toxic dilatation in ulcerative and Crohn's colitis. J Clin Gastroenterol. 1985 Apr;7(2):137-43. Resumo

4. Ausch C, Madoff RD, Gnant M, et al. Aetiology and surgical management of toxic megacolon. Colorectal Dis. 2006 Mar;8(3):195-201. Resumo

5. Dallal RM, Harbrecht BG, Boujoukas AJ, et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg. 2002 Mar;235(3):363-72.Texto completo  Resumo

6. Doshi R, Desai J, Shah Y, et al. Incidence, features, in-hospital outcomes and predictors of in-hospital mortality associated with toxic megacolon hospitalizations in the United States. Intern Emerg Med. 2018 Sep;13(6):881-7. Resumo

7. Bellary SV, Isaacs P. Toxic megacolon (TM) due to Salmonella. J Clin Gastroenterol. 1990 Oct;12(5):605-7. Resumo

8. Tiao MM, Huang HC, Huang CB, et al. Toxic megacolon in Salmonella colitis: report of two cases. Acta Paediatr Taiwan. 2000 Jan-Feb;41(1):43-6. Resumo

9. Upadhyay AK, Neely JA. Toxic megacolon and perforation caused by Shigella. Br J Surg. 1989 Nov;76(11):1217. Resumo

10. Anderson JB, Tanner AH, Brodribb AJ. Toxic megacolon due to Campylobacter colitis. Int J Colorectal Dis. 1986 Jan;1(1):58-9. Resumo

11. McGregor A, Brown M, Thway K, et al. Fulminant amoebic colitis following loperamide use. J Travel Med. 2007 Jan-Feb;14(1):61-2.Texto completo  Resumo

12. Beaugerie L, Ngo Y, Goujard F, et al. Etiology and management of toxic megacolon in patients with human immunodeficiency virus infection. Gastroenterology. 1994 Sep;107(3):858-63. Resumo

13. Cooper HS, Raffensperger EC, Jonas L, et al. Cytomegalovirus inclusions in patients with ulcerative colitis and toxic dilation requiring colonic resection. Gastroenterology. 1977 Jun;72(6):1253-6. Resumo

14. Criscuoli V, Rizzuto MR, Gallo E, et al. Toxic megacolon and human Cytomegalovirus in a series of severe ulcerative colitis patients. J Clin Virol. 2015 May;66:103-6. Resumo

15. Present DH. Toxic megacolon. Med Clin North Am. 1993 Sep;77(5):1129-48. Resumo

16. Atherton LD, Leib ES, Kaye MD. Toxic megacolon associated with methotrexate therapy. Gastroenterology. 1984 Jun;86(6):1583-8. Resumo

17. Lee FY, Lin HY, Pan S, et al. Gold-induced fulminant colitis in a patient with psoriatic arthritis. J Clin Gastroenterol. 1988 Feb;10(1):116-7. Resumo

18. de Gara CJ, Gagic N, Arnold A, et al. Toxic megacolon associated with anticancer chemotherapy. Can J Surg. 1991 Aug;34(4):339-41. Resumo

19. Gan SI, Beck PL. A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management. Am J Gastroenterol. 2003 Nov;98(11):2363-71. Resumo

20. Sheth SG, LaMont JT. Toxic megacolon. Lancet. 1998 Feb 14;351(9101):509-13. Resumo

21. Solomon K. The host immune response to Clostridium difficile infection. Ther Adv Infect Dis. 2013 Feb;1(1):19-35.Texto completo  Resumo

22. McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018 Mar 19;66(7):987-94.Texto completo  Resumo

23. Imbriaco M, Balthazar EJ. Toxic megacolon: role of CT in evaluation and detection of complications. Clin Imaging. 2001 Sep-Oct;25(5):349-54. Resumo

24. Jalan KN, Sircus W, Card WI, et al. An experience of ulcerative colitis. I. Toxic dilation in 55 cases. Gastroenterology. 1969 Jul;57(1):68-82. Resumo

25. Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021 Nov 1;49(11):e1063-143.Texto completo  Resumo

26. Rhodes A, Phillips G, Beale R, et al. The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study). Intensive Care Med. 2015 Sep;41(9):1620-8. Resumo

27. Levy MM, Rhodes A, Phillips GS, et al. Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Intensive Care Med. 2014 Nov;40(11):1623-33.Texto completo  Resumo

28. Seymour CW, Gesten F, Prescott HC, et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017 Jun 8;376(23):2235-44.Texto completo  Resumo

29. Zar FA, Bakkanagari SR, Moorthi KM, et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007 Aug 1;45(3):302-7.Texto completo  Resumo

30. Cocanour CS. Best strategies in recurrent or persistent Clostridium difficile infection. Surg Infect (Larchmt). 2011 Jun;12(3):235-9. Resumo

31. Kim PK, Huh HC, Cohen HW, et al. Intracolonic vancomycin for severe Clostridium difficile colitis. Surg Infect (Larchmt). 2013 Dec;14(6):532-9.Texto completo  Resumo

32. Klobuka AJ, Markelov A. Current status of surgical treatment for fulminant clostridium difficile colitis. World J Gastrointest Surg. 2013 Jun 27;5(6):167-72.Texto completo  Resumo

33. Teeuwen PH, Stommel MW, Bremers AJ, et al. Colectomy in patients with acute colitis: a systematic review. J Gastrointest Surg. 2009 Apr;13(4):676-86. Resumo

34. NHS Improvement. Patient Safety review and response: April to September 2018. March 2019 [internet publication].Texto completo

35. NHS England. Patient safety alert on placement devices for nasogastric tube insertion. 5 December 2013 [internet publication].Texto completo

36. Neal MD, Alverdy JC, Hall DE, et al. Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease. Ann Surg. 2011 Sep;254(3):423-7. Resumo

37. Pola S, Patel D, Ramamoorthy S, et al. Strategies for the care of adults hospitalized for active ulcerative colitis. Clin Gastroenterol Hepatol. 2012 Dec;10(12):1315-25.Texto completo  Resumo

38. Actis GC, Ottobrelli A, Pera A, et al. Continuously infused cyclosporine at low dose is sufficient to avoid emergency colectomy in acute attacks of ulcerative colitis without the need for high-dose steroids. J Clin Gastroenterol. 1993 Jul;17(1):10-3. Resumo

39. van Geenen EJ, Sachar DB. Infliximab in Crohn's disease-associated toxic megacolon. J Clin Gastroenterol. 2012 Apr;46(4):321-3. Resumo

40. Sinagra E, Orlando A, Renna S, et al. Is really megacolon a contraindication to infliximab in Crohn's disease? Acta Gastroenterol Belg. 2013 Dec;76(4):442-4. Resumo

41. Narabayashi K, Inoue T, Sakanaka T, et al. Oral tacrolimus for megacolon in patients with severe ulcerative colitis. Intern Med. 2014;53(16):1755-8.Texto completo  Resumo

42. Hayashi R, Ueno Y, Tanaka S, et al. Two cases of severe ulcerative colitis with colonic dilatation resolved with tacrolimus therapy. Case Rep Gastroenterol. 2015 Jul 31;9(2):272-7.Texto completo  Resumo

43. Mitsuyama K, Sata M. Therapeutic leukocytapheresis in inflammatory bowel disease: clinical efficacy and mechanisms of action. Cytotherapy. 2009;11(2):229-37. Resumo

44. Kanai T, Hibi T, Watanabe M. The logics of leukocytapheresis as a natural biological therapy for inflammatory bowel disease. Expert Opin Biol Ther. 2006 May;6(5):453-66. Resumo

45. Yokoyama Y, Matsuoka K, Kobayashi T, et al. A large-scale, prospective, observational study of leukocytapheresis for ulcerative colitis: treatment outcomes of 847 patients in clinical practice. J Crohns Colitis. 2014 Sep;8(9):981-91.Texto completo  Resumo

46. Cammarota G, Ianiro G, Gasbarrini A. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol. 2014 Sep;48(8):693-702. Resumo

47. Gweon TG, Lee KJ, Kang DH, et al. A case of toxic megacolon caused by Clostridium difficile infection and treated with fecal microbiota transplantation. Gut Liver. 2015 Mar;9(2):247-50.Texto completo  Resumo

48. Yu S, Abdelkarim A, Nawras A, et al. Fecal transplant for treatment of toxic megacolon associated with Clostridium difficile colitis in a patient with Duchenne muscular dystrophy. Am J Ther. 2016 Mar-Apr;23(2):e609-13. Resumo

49. Trudel JL, Deschenes M, Mayrand S, et el. Toxic megacolon complicating pseudomembranous enterocolitis. Dis Colon Rectum. 1995 Oct;38(10):1033-8. Resumo

50. Grant CS, Dozois RR. Toxic megacolon: ultimate fate of patients after successful medical management. Am J Surg. 1984 Jan;147(1):106-10. Resumo

51. Berman L, Carling T, Fitzgerald TN, et al. Defining surgical therapy for pseudomembranous colitis with toxic megacolon. J Clin Gastroenterol. 2008 May-Jun;42(5):476-80. Resumo

52. Perera AD, Akbari RP, Cowher MS, et al. Colectomy for fulminant Clostridium difficile colitis: predictors of mortality. Am Surg. 2010 Apr;76(4):418-21. Resumo

53. Osman KA, Ahmed MH, Hamad MA, et al. Emergency colectomy for fulminant Clostridium difficile colitis: striking the right balance. Scand J Gastroenterol. 2011 Oct;46(10):1222-7. Resumo

54. Borgia G, Maraolo AE, Foggia M, et al. Fecal microbiota transplantation for Clostridium difficile infection: back to the future. Expert Opin Biol Ther. 2015 Jul;15(7):1001-14. Resumo

O uso deste conteúdo está sujeito ao nosso aviso legal